00000740467/31Accelerated Filerfalse10/31/20242025Q1FALSEo127,945111,43887,16580,44740,78030,99119,59017,83521,19013,15673436115017540414098832620,20212,8303,8262,08816,37610,7422.431.611.821.212.251.501.821.214,9224,8271,9841,9676,9066,7941,9841,9670.3100.2900.2330.21816,37610,7422119211664218516,33410,557P1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesxbrli:pureodc:segment00000740462024-08-012024-10-310000074046us-gaap:CommonStockMember2024-11-300000074046us-gaap:CommonClassBMember2024-11-3000000740462024-10-3100000740462024-07-310000074046us-gaap:CommonStockMember2024-10-310000074046us-gaap:CommonStockMember2024-07-310000074046us-gaap:CommonClassBMember2024-10-310000074046us-gaap:CommonClassBMember2024-07-3100000740462023-08-012023-10-310000074046us-gaap:CommonStockMember2024-08-012024-10-310000074046us-gaap:CommonStockMember2023-08-012023-10-310000074046us-gaap:CommonClassBMember2024-08-012024-10-310000074046us-gaap:CommonClassBMember2023-08-012023-10-310000074046us-gaap:CommonStockMember2023-07-310000074046us-gaap:TreasuryStockCommonMember2023-07-310000074046us-gaap:AdditionalPaidInCapitalMember2023-07-310000074046us-gaap:RetainedEarningsMember2023-07-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-3100000740462023-07-310000074046us-gaap:CommonStockMember2023-08-012023-10-310000074046us-gaap:AdditionalPaidInCapitalMember2023-08-012023-10-310000074046us-gaap:RetainedEarningsMember2023-08-012023-10-310000074046us-gaap:TreasuryStockCommonMember2023-08-012023-10-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-08-012023-10-310000074046us-gaap:CommonStockMember2023-10-310000074046us-gaap:TreasuryStockCommonMember2023-10-310000074046us-gaap:AdditionalPaidInCapitalMember2023-10-310000074046us-gaap:RetainedEarningsMember2023-10-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-10-3100000740462023-10-310000074046us-gaap:CommonStockMember2024-07-310000074046us-gaap:TreasuryStockCommonMember2024-07-310000074046us-gaap:AdditionalPaidInCapitalMember2024-07-310000074046us-gaap:RetainedEarningsMember2024-07-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-310000074046us-gaap:CommonStockMember2024-08-012024-10-310000074046us-gaap:AdditionalPaidInCapitalMember2024-08-012024-10-310000074046us-gaap:RetainedEarningsMember2024-08-012024-10-310000074046us-gaap:TreasuryStockCommonMember2024-08-012024-10-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-08-012024-10-310000074046us-gaap:CommonStockMember2024-10-310000074046us-gaap:TreasuryStockCommonMember2024-10-310000074046us-gaap:AdditionalPaidInCapitalMember2024-10-310000074046us-gaap:RetainedEarningsMember2024-10-310000074046us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-310000074046us-gaap:UpFrontPaymentArrangementMember2024-10-310000074046us-gaap:UpFrontPaymentArrangementMember2024-07-310000074046us-gaap:UpFrontPaymentArrangementMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonStockMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonStockMember2023-08-012023-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonClassBMember2023-08-012023-10-310000074046us-gaap:FairValueInputsLevel1Member2024-10-310000074046us-gaap:FairValueInputsLevel1Member2024-07-310000074046us-gaap:FairValueInputsLevel2Member2024-10-310000074046us-gaap:FairValueInputsLevel2Member2024-07-310000074046odc:UltraPetMember2024-07-310000074046srt:MinimumMember2024-10-310000074046srt:MaximumMember2024-10-310000074046odc:SeriesBSeniorNotesMember2024-08-012024-10-310000074046odc:SeriesBSeniorNotesMember2024-10-310000074046odc:SeriesCSeniorNotesMember2024-08-012024-10-310000074046odc:SeriesCSeniorNotesMember2024-10-310000074046odc:SeriesDSeniorNotesMember2024-08-012024-10-310000074046odc:SeriesDSeniorNotesMember2024-10-310000074046us-gaap:LineOfCreditMember2024-10-310000074046us-gaap:LetterOfCreditMember2024-10-310000074046us-gaap:LineOfCreditMember2024-07-310000074046us-gaap:LetterOfCreditMember2024-07-310000074046us-gaap:LineOfCreditMember2024-08-012024-10-310000074046us-gaap:LineOfCreditMemberus-gaap:PrimeRateMember2024-10-310000074046us-gaap:LineOfCreditMemberus-gaap:SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember2024-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:CatLitterMember2024-08-012024-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:CatLitterMember2023-08-012023-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:CatLitterMember2024-08-012024-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:CatLitterMember2023-08-012023-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:IndustrialandSportsMember2024-08-012024-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:IndustrialandSportsMember2023-08-012023-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:IndustrialandSportsMember2024-08-012024-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:IndustrialandSportsMember2023-08-012023-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:AgriculturalandHorticulturalMember2024-08-012024-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:AgriculturalandHorticulturalMember2023-08-012023-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:AgriculturalandHorticulturalMember2024-08-012024-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:AgriculturalandHorticulturalMember2023-08-012023-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:BleachingClayandFluidsPurificationMember2024-08-012024-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:BleachingClayandFluidsPurificationMember2023-08-012023-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:BleachingClayandFluidsPurificationMember2024-08-012024-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:BleachingClayandFluidsPurificationMember2023-08-012023-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:AnimalHealthandNutritionMember2024-08-012024-10-310000074046odc:BusinesstoBusinessSegmentMemberodc:AnimalHealthandNutritionMember2023-08-012023-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:AnimalHealthandNutritionMember2024-08-012024-10-310000074046odc:RetailAndWholesaleSegmentMemberodc:AnimalHealthandNutritionMember2023-08-012023-10-310000074046odc:BusinesstoBusinessSegmentMember2024-08-012024-10-310000074046odc:BusinesstoBusinessSegmentMember2023-08-012023-10-310000074046odc:RetailAndWholesaleSegmentMember2024-08-012024-10-310000074046odc:RetailAndWholesaleSegmentMember2023-08-012023-10-310000074046odc:BusinesstoBusinessSegmentMember2024-10-310000074046odc:BusinesstoBusinessSegmentMember2024-07-310000074046odc:RetailAndWholesaleSegmentMember2024-10-310000074046odc:RetailAndWholesaleSegmentMember2024-07-310000074046us-gaap:AllOtherSegmentsMember2024-10-310000074046us-gaap:AllOtherSegmentsMember2024-07-310000074046odc:A2006PlanMember2024-10-310000074046srt:MinimumMemberus-gaap:RestrictedStockMemberodc:A2006PlanMember2024-08-012024-10-310000074046srt:MaximumMemberus-gaap:RestrictedStockMemberodc:A2006PlanMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonStockMemberodc:A2006PlanMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonStockMemberodc:A2006PlanMember2023-08-012023-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonClassBMemberodc:A2006PlanMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMemberus-gaap:CommonClassBMemberodc:A2006PlanMember2023-08-012023-10-310000074046us-gaap:RestrictedStockMemberodc:A2006PlanMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMemberodc:A2006PlanMember2023-08-012023-10-310000074046us-gaap:RestrictedStockMember2024-07-310000074046us-gaap:RestrictedStockMember2024-08-012024-10-310000074046us-gaap:RestrictedStockMember2024-10-310000074046us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-07-310000074046us-gaap:AccumulatedTranslationAdjustmentMember2024-07-310000074046us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-08-012024-10-310000074046us-gaap:AccumulatedTranslationAdjustmentMember2024-08-012024-10-310000074046us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember2024-10-310000074046us-gaap:AccumulatedTranslationAdjustmentMember2024-10-310000074046srt:DirectorMember2024-08-012024-10-310000074046srt:DirectorMember2023-08-012023-10-310000074046srt:DirectorMember2024-07-310000074046srt:DirectorMember2024-10-31


美国

证券和交易委员会

华盛顿特区 20549

表格 10-Q
(请选择一项)        
根据1934年证券交易法第13或第15(d)条规定的季度报告
截至2024年10月31日的季度期间
or
根据1934年证券交易法第13或15(d)条款的过渡报告
在从_____________到_____________的过渡期间

委员会文件号 001-12622

美国奥德赛公司
(按其章程规定规定的准确名称的发起人)
特拉华州
  36-2048898
(注册或设立的州或其他司法管辖区) (内部税务局雇主识别号码)
 410 北密歇根大道, 400套房
芝加哥, Illinois
 60611-4213
(总部地址)(邮政编码)
注册者的电话号码,包括区号:(312) 321-1515
在法案第12(b)条的规定下注册的证券:
每个类别的标题交易标的在其上注册的交易所的名称
普通股,每股面值0.10美元ODC纽约证券交易所

请用勾号指明注册人是否在过去12个月(或注册人被要求提交该报告的较短期间内)根据1934年证券交易法第13条或第15(d)条提交了所有必须提交的报告,并且在过去至少90天内是否受到此类提交要求的约束。

请在方框内划勾,以指示注册人是否已在过去12个月内(或注册人所需提交此类文件的较短期间内)递交并张贴了根据规则405条款的电子交互数据文件(本章节第232.405条)。

√ 大型快速归档人   √加速归档人   √非加速归档人   ¨较小报告公司   ¨新兴成长型公司 请参见《交易所法》第12亿.2条中对“大型快速归档人”、“加速归档人”、“较小的报告公司”和“新兴成长型公司”的定义。
Large Accelerated Filer o
非加速归档者o
加速存取器 x
小型报告公司o
新兴成长公司o

如果是新兴成长型公司,请在复选框中打勾,以确定注册人是否选择不使用在1934年证券交易法第13(a)条项下提供的任何新的或修订的财务会计准准则的延长过渡期。

请在复选框中选中,以指示注册人是否为空壳公司(根据交易所法规12b-2定义)。 是

截至2024年11月30日, 5,159,843 公司普通股份股数为 2,137,428 公司B类股份股数为。




目录
 
  
 第一部分 - 财务信息 
  页面
Item 1:
   
项目2:
   
条款 3:
   
项目4:
   
 第二部分- 其他信息 
项目1A:
项目2:
项目4:
条款 6:
   

前瞻性声明

本报告中的某些陈述,包括但不限于“管理层财务状况和运营成果的讨论与分析”标题下的陈述,以及本报告和我们向证券交易委员会("SEC")提交的其他文件中的陈述,包含了根据1995年美国私人证券诉讼改革法案的安全港条款定义的前瞻性陈述,这些陈述基于对我们未来绩效、我们的业务、我们的信念和管理层的假设的当前期望、估算、预测和展望。此外,我们或代表我们的人可能在新闻稿或书面声明中,或在我们与投资者和分析师的正常业务通信和讨论中通过会议、网络广播、电话和电话会议做出前瞻性陈述。前瞻性陈述可以通过“期望”、“展望”、“预测”、“将”、“可以”、“应该”、“计划”、“继续”、“相信”、“寻求”、“估计”、“预期”、“可能”、“假设”、“潜在”、“努力”和对未来时期的类似引用来识别。

此类声明受到某些风险、不确定性和假设的影响,这可能导致实际结果大幅不同,包括但不限于本文件及我们截至2024年7月31日财政年度的10-K表格年报中所述的第1A项"风险因素"。 不时在我们其他向SEC提交的文件中。如果这些或其他风险或不确定性中的一个或多个变为现实,或者基本假设被证明不正确,实际结果可能与任何前瞻性声明中预期、意图、期望、相信、估计、预测、计划或以其他方式表达的结果大相径庭。投资者被提醒不要对这些前瞻性声明过分依赖,这些声明仅在本日期有效。除非法律要求,否则我们没有任何意图或义务在本报告发布后公开更新任何前瞻性声明,无论是由于新信息、未来事件、假设变化还是其他原因。
 
商标公告

"Oil-Dri" 是美国Oil-Dri公司注册的商标。
2



第一部分 - 财务信息

项目1. 基本报表

美国奥德赛公司
简明合并资产负债表
(以千为单位,除分享和每股金额外,未经审计)

资产选定的合并营运信息:
2024
7月31日,
2024
流动资产  
现金及现金等价物$12,506 $23,481 
应收账款净额
的$1,562 and $934 截至2024年10月31日和2024年7月31日
70,544 62,171 
净存货56,025 54,236 
预付款和其他资产5,040 7,270 
流动资产合计144,115 147,158 
其他资产  
物业、厂房和设备,净值137,947 137,796 
商誉15,674 15,443 
商标、商号和专利,减去累计摊销
员工福利计划647 and $625 截至2024年10月31日和2024年7月31日,分别
6,632 6,662 
客户清单,减去累计摊销
员工福利计划8,431 and $8,149 截至2024年10月31日和2024年7月31日,分别
19,754 20,036 
递延所得税1,075 1,537 
经营租赁使用权资产17,552 18,667 
其他 7,422 7,306 
其他资产总额206,056 207,447 
总资产$350,171 $354,605 


随附的附注是简明合并财务报表不可分割的一部分。

3



美国奥德赛公司
浓缩合并资产负债表(续)
(以千为单位,除分享和每股金额外,未经审计)

负债和股东权益选定的合并营运信息:
2024
7月31日,
2024
流动负债  
票据应付的流动部分$1,000 $1,000 
应付账款13,824 15,009 
应付股息2,098 2,096 
营运租赁负债4,476 4,556 
应计费用33,443 44,016 
总流动负债54,841 66,677 
2017年11月30日  
长期债务,扣除未摊销的债务发行成本
为这些收购造成了223 and $226 截至2024年10月31日和2024年7月31日
44,777 49,774 
延期补偿5,664 5,667 
长期经营租赁负债14,294 15,391 
其他6,603 6,508 
非流动负债合计71,338 77,340 
总负债126,179 144,017 
承诺和或有事项(见第7条)
股东权益  
普通股,每股面值 $.10 每股发行 8,884,473 在2024年10月31日的股份
  和 8,843,673 在2024年7月31日的股份
888 884 
B类股票,面值$.10 每股发行 2,518,056 在2024年10月31日的股份
  和 2,518,056 在2024年7月31日的股份
252 252 
追加实收资本62,601 60,877 
留存收益246,525 232,247 
累计其他综合收益727 769 
减持库藏股,按成本(3,723,947 普通股和 380,628 B类股票额度为
截止到2024年10月31日及 3,702,185 普通股和 362,649 截止2024年7月31日的B类股份
(87,001)(84,441)
股东权益合计223,992 210,588 
负债和股东权益总计$350,171 $354,605 


The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
4



OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Operations
(in thousands, except for share and per share amounts, unaudited)
For the Three Months Ended October 31,
 20242023
Net Sales$127,945 $111,438 
Cost of Goods Sold(87,165)(80,447)
Gross Profit40,780 30,991 
Selling, General and Administrative Expenses(19,590)(17,835)
Income from Operations21,190 13,156 
Other (Expense) Income   
Interest expense(734)(361)
Interest income150 175 
Other, net(404)(140)
Total Other Expense, Net(988)(326)
Income Before Income Taxes20,202 12,830 
Income Tax Expense(3,826)(2,088)
Net Income16,376 10,742 
Earnings Per Share
Basic Common$2.43 $1.61 
Basic Class B$1.82 $1.21 
Diluted Common $2.25 $1.50 
   Diluted Class B$1.82 $1.21 
Average Shares Outstanding
Basic Common4,922 4,827 
Basic Class B1,984 1,967 
Diluted Common6,906 6,794 
   Diluted Class B1,984 1,967 
Dividends Declared Per Share
Common Stock$0.310 $0.290 
Class B Stock$0.233 $0.218 


The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
5



OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Comprehensive Income
(in thousands, unaudited)

For the Three Months Ended October 31,
 20242023
Net Income$16,376 $10,742 
Other Comprehensive Loss:
Postretirement expenses (net of tax)(21)(19)
Cumulative translation adjustment(21)(166)
Other Comprehensive Loss:(42)(185)
Total Comprehensive Income$16,334 $10,557 

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.







































6



OIL-DRI CORPORATION OF AMERICA
Consolidated Statements of Stockholders' Equity
(in thousands, except for share amounts, unaudited)
For the Three Months Ended October 31
Number of Shares
Common & Class B StockTreasury StockCommon & Class B StockAdditional Paid-In CapitalRetained EarningsTreasury StockAccumulated Other Comprehensive IncomeTotal Stockholders' Equity
Balance, July 31, 202311,147,279 (4,010,630)$1,115 $55,624 $200,796 $(81,207)$748 $177,076 
Net Income— —   10,742   10,742 
Other Comprehensive Loss— —     (185)(185)
Dividends Declared— —   (1,953)  (1,953)
Purchases of Treasury Stock— (15,329)   (872) (872)
Net issuance of stock under long-term incentive plans182,000 (500)18 14  (32)  
Amortization of Restricted Stock— —  1,108    1,108 
Balance, October 31, 202311,329,279 (4,026,459)$1,133 $56,746 $209,585 $(82,111)$563 $185,916 
Balance, July 31, 202411,361,729 (4,064,834)$1,136 $60,877 $232,247 $(84,441)$769 $210,588 
Net Income— —   16,376   16,376 
Other Comprehensive Loss— —     (42)(42)
Dividends Declared— —   (2,098)  (2,098)
Purchases of Treasury Stock— (29,002)   (1,984) (1,984)
Net issuance of stock under long-term incentive plans40,800 (10,739)4 572  (576)  
Amortization of Restricted Stock— —  1,152    1,152 
Balance, October 31, 202411,402,529 (4,104,575)$1,140 $62,601 $246,525 $(87,001)$727 $223,992 



The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.

7



OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Cash Flows
(in thousands, unaudited)
For the Three Months Ended October 31,
CASH FLOWS FROM OPERATING ACTIVITIES20242023
Net Income$16,376 $10,742 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization5,381 4,368 
Non-cash stock-based compensation1,152 1,108 
Provision for bad debts and cash discounts628 28 
Loss on impairment of patent applications48  
    Accretion of asset retirement obligation47 53 
Loss on the disposals of property, plant and equipment80 26 
(Increase) decrease in assets:  
Accounts receivable(9,020)(1,487)
Inventories(2,033)(1,374)
Prepaid expenses2,228 154 
Deferred income taxes
462 174 
Other assets962 341 
Increase (decrease) in liabilities:  
Accounts payable1,889 (1,289)
Accrued expenses(6,117)(4,365)
Deferred compensation(3)512 
Other liabilities(1,161)(427)
Total Adjustments(5,457)(2,178)
Net Cash Provided by Operating Activities10,919 8,564 
CASH FLOWS FROM INVESTING ACTIVITIES  
Capital expenditures(12,817)(8,064)
Net Cash Used in Investing Activities(12,817)(8,064)
CASH FLOWS FROM FINANCING ACTIVITIES  
Payments on revolving credit facility(5,000) 
Dividends paid(2,096)(1,927)
Purchases of treasury stock(1,984)(872)
Net Cash Used in Financing Activities(9,080)(2,799)
Effect of exchange rate changes on cash and cash equivalents3 124 
Net Decrease in Cash and Cash Equivalents(10,975)(2,175)
Cash, Cash Equivalents and Restricted Cash, Beginning of Period24,481 31,754 
Cash, Cash Equivalents and Restricted Cash, End of Period$13,506 $29,579 

The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.
8




OIL-DRI CORPORATION OF AMERICA
Condensed Consolidated Statements of Cash Flows - Continued
(in thousands, unaudited)

For the Three Months Ended October 31,
20242023
Supplemental disclosures:
Reconciliation of cash, cash equivalents and restricted cash
Cash and cash equivalents$12,506 $29,579 
Restricted cash in prepaid expenses and other assets$1,000 $ 
Other cash flows:
    Interest payments, net of amounts capitalized$324 $ 
    Income tax payments, net of refunds
265 12 
Non-cash investing and financing activities:
Change in capital expenditures in accounts payable$(2,962)$(843)
Change in capital expenditures in accrued expenses$(4,540)$96 
Cash dividends declared and accrued$2,098 $1,953 


The accompanying notes are an integral part of the Condensed Consolidated Financial Statements.


9



OIL-DRI CORPORATION OF AMERICA
Notes To Condensed Consolidated Financial Statements
(Unaudited)

1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The accompanying unaudited Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP") for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. The financial statements and the related notes are condensed and should be read in conjunction with the Consolidated Financial Statements and related notes included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2024.

The unaudited Condensed Consolidated Financial Statements include the accounts of Oil-Dri Corporation of America and its subsidiaries. All significant intercompany transactions are eliminated. Except as otherwise indicated herein or as the context otherwise requires, references to "Oil-Dri," the "Company," "we," "us" or "our" refer to Oil-Dri Corporation of America and its subsidiaries.

The unaudited Condensed Consolidated Financial Statements reflect all adjustments, consisting of normal recurring accruals and reclassifications which are, in the opinion of management, necessary for a fair presentation of the statements contained herein. Operating results for the three months ended October 31, 2024 are not necessarily an indication of the results that may be expected for the fiscal year ending July 31, 2025.

Certain amounts in the prior period financial statements have been reclassified to conform to the presentation of the current period financial statements. These immaterial reclassifications had no effect on the previously reported net income.

Management Use of Estimates

The preparation of the unaudited Condensed Consolidated Financial Statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses during the reporting period, as well as the related disclosures. Estimates and assumptions about future events cannot be made with certainty. All of our estimates and assumptions are revised periodically. Actual results could differ from these estimates.

Summary of Significant Accounting Policies

Our significant accounting policies, which are summarized in detail in our Annual Report on Form 10-K for the fiscal year ended July 31, 2024, have not materially changed. The following is a description of certain of our significant accounting policies:

Trade Receivables. We recognize trade receivables when control of finished products are transferred to our customers. We record an allowance for credit losses based on our expectations and a periodic review of our accounts receivable, including a review of the overall aging of accounts, consideration of customer credit risk and analysis of facts and circumstances about specific accounts. A customer account is determined to be uncollectible when it is probable that a loss will be incurred after we have completed our internal collection procedures, including termination of shipments, direct customer contact and formal demand of payment. We retain outside collection agencies to facilitate our collection efforts. Past due status is determined based on contractual terms and customer payment history. We also include an allowance for expected cash discounts to be taken.

Property, Plant and Equipment. Property, plant and equipment includes depreciable assets such as building, machinery, equipment, furniture, vehicles, and capitalized spare parts. These assets are depreciated using the straight-line method over their estimated useful lives. Major improvements are capitalized, while maintenance and repairs that do not extend the useful life of the applicable assets are expensed as incurred. Interest expense may also be capitalized for assets that require a period of time to get them ready for their intended use.

These assets are carried at cost on the Consolidated Balance Sheets and are reviewed for possible impairment on an annual basis or when circumstances indicate impairment that an asset may become impaired. We take into consideration idle and
10



underutilized equipment and review business plans for possible impairment. When impairment is indicated, an impairment charge is recorded for the difference between the carrying value of the asset and its fair market value.
The composition of property, plant and equipment is as follows (in thousands):
October 31,
2024
July 31,
2024
Gross property, plant and equipment335,921 333,561 
Accumulated depreciation and amortization(197,974)(195,765)
Total Property, Plant and Equipment, Net$137,947 $137,796 


Land, Mining Property and Mineral Rights. We surface mine sorbent materials on property that we either own or lease as part of our overall operations. A significant part of our overall mining cost is incurred during the process of removing the overburden (non-usable material) from the mine site, thus exposing the sorbent material used in a majority of our production processes. These stripping costs are treated as a variable inventory production cost and are included in cost of goods sold in the period they are incurred. We defer and amortize the pre-production overburden removal costs during the development phase associated with opening a new mine.

Additionally, it is our policy to capitalize the purchase cost of land and mineral rights, including associated legal fees, survey fees and real estate fees. The costs of obtaining mineral patents, including legal fees and drilling expenses, are also capitalized. Pre-production development costs on new mines and any prepaid royalties that may be offset against future royalties due upon extraction of the minerals are also capitalized. All exploration related costs are expensed as incurred.

Reclamation. We perform ongoing reclamation activities during the normal course of our overburden removal. As overburden is removed from a mine site, it is hauled to previously mined sites and is used to refill older sites. This process allows us to continuously reclaim older mine sites and dispose of overburden simultaneously, therefore minimizing the costs associated with the reclamation process.

On an annual basis we evaluate our potential reclamation liability in accordance with ASC 410, Asset Retirement and Environmental Obligations. The reclamation assets are depreciated over the estimated useful lives of the respective mines. The reclamation liabilities are increased based on a yearly accretion charge over the estimated useful lives of the respective mines.

Leases. ASC 842, Leases, provides that a contract is, or contains, a lease if it conveys the right to control the use of an identified asset and, accordingly, a lease liability and a related right-of-use ("ROU") asset is recognized at the commencement date on our consolidated balance sheet. As provided in ASC 842, we have elected not to apply these measurement and recognition requirements to short-term leases (i.e., leases with a term of 12 months or less). Short-term leases will not be recorded as ROU assets or lease liabilities on our consolidated balance sheet, and the related lease payments will be recognized in net earnings on a straight-line basis over the lease term. For leases other than short-term leases, the lease liability is equal to the present value of unpaid lease payments over the remaining lease term. The lease term may reflect options to extend or terminate the lease when it is reasonably certain that such options will be exercised. To determine the present value of the lease liability, we used an incremental borrowing rate, which is defined as the rate of interest we would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. The ROU asset is based on the corresponding lease liability adjusted for certain costs such as initial direct costs, prepaid lease payments and lease incentives received. Both operating and finance lease ROU assets are reviewed for impairment, consistent with other long-lived assets, whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. After a ROU asset is impaired, any remaining balance of the ROU asset is amortized on a straight-line basis over the shorter of the remaining lease term or the estimated useful life. After the lease commencement date, we evaluate lease modifications, if any, that could result in a change in the accounting for leases.

Certain of our leases provide for variable lease payments that vary due to changes in facts and circumstances occurring after the commencement date, other than the passage of time. Variable lease payments that are dependent on an index or rate (e.g., the Consumer Price Index) are included in the initial measurement of the lease liability and the ROU asset. Variable lease payments that are not known at the commencement date and are determinable based on the performance or use of the underlying asset, are expensed as incurred. Our variable lease payments primarily include common area maintenance charges based on the percentage of the total square footage leased and the usage of assets, such as photocopiers.

Some of our contracts may contain lease components as well as non-lease components, such as an agreement to purchase services. As allowed under ASC 842, we have elected not to separate the lease components from non-lease components for all
11



asset classes and we will not allocate the contract consideration to these components. This policy was applied to all existing leases upon adoption of ASC 842 and will be applied to new leases on an ongoing basis.

Revenue Recognition. We recognize revenue when performance obligations under the terms of the contracts with customers are satisfied. Our performance obligation generally consists of the promise to sell finished products to wholesalers, distributors and retailers or consumers and our obligations have an original duration of one year or less. Control of the finished products are transferred upon shipment to, or receipt at, customers' locations, as determined by the specific terms of the contract. We have completed our performance obligation when control is transferred and we recognize revenue accordingly. Taxes collected from customers and remitted to governmental authorities are excluded from net sales. Sales returns are not material nor are warranties and any related obligations.

We have an unconditional right to consideration under the payment terms specified in the contracts upon completion of the
performance obligation. We may require certain customers to provide payment in advance of product shipment. We recorded a
liability for these advance payments of $0.2 million as of both October 31, 2024 and July 31, 2024. This liability is reported in Other within Accrued Expenses on the unaudited Condensed Consolidated Balance Sheet. There was $0.2 million revenue recognized during the three months ended October 31, 2024, that was included in the liability for advance payments at the beginning of the period.

We routinely commit to one-time or ongoing trade promotion programs directly with consumers, such as coupon programs, and with customers, such as volume discounts, cooperative marketing and other arrangements. We estimate and accrue the expected costs of these programs. These costs are considered variable consideration under ASC 606, Revenue from Contracts with Customers, and are netted against sales when revenue is recorded. The accruals are based on our best estimate of the amounts necessary to settle future and existing obligations on products sold as of the balance sheet date. To estimate these accruals, we rely on our historical experience of trade spending patterns and that of the industry, current trends and forecasted data.

Selling, General and Administrative Expenses. Selling, general and administrative expenses ("SG&A") include salaries, wages and benefits associated with staff outside the manufacturing and distribution functions, all marketing related costs, any miscellaneous trade spending expenses not required to be included in net sales, research and development costs, depreciation and amortization related to assets outside the manufacturing and distribution process and all other non-manufacturing and non-distribution expenses.

Other Current and Noncurrent Liabilities. Other liabilities include the accruals for general expenses not yet paid, cash collected not yet vouchered, legal reserves, postretirement health benefit obligations, and reclamation liability accrual. Current liabilities are due to be paid within the next 12 months. Other noncurrent liabilities on the unaudited Condensed Consolidated Balance Sheet includes $4.8 million for the reclamation liability as of both October 31, 2024 and July 31, 2024 and $1.7 million for postretirement health benefit as of both October 31, 2024 and July 31, 2024, respectively.

New Accounting Pronouncements and Regulations.

Recently Issued Accounting Standards Not Yet Adopted

In December 2023, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2023-09, "Income Taxes (Topic 740): Improvements to Income Tax Disclosures." These amendments primarily require enhanced disclosures and disaggregation of income tax information by jurisdiction in the annual income tax reconciliation and quantitative disclosures regarding income taxes paid. These amendments are to be applied prospectively, with the option to apply the standard retrospectively, for annual periods beginning after December 15, 2024. Early adoption is permitted. We are currently evaluating the impact that the adoption of this guidance will have on our disclosures.

In November 2023, the FASB issued ASU No. 2023-07, "Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures." These amendments primarily require enhanced disclosures about significant segment expenses regularly provided to the chief operating decision maker and included within each reported measure of segment profit or loss. In addition, ASU No. 2023-07 also requires all annual disclosures currently required by Topic 280 to be included in interim periods. These amendments are to be applied retrospectively for all periods presented in the financial statements and are effective for fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024, with early adoption permitted. We are currently evaluating the impact that the adoption of this guidance will have on our disclosures.
12



In November 2024, the FASB issued ASU No. 2024-03, "Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40)." These amendments primarily require disaggregated disclosure, in the notes to the financial statements, of prescribed categories of expenses within relevant income statement captions. The requirements will be applied prospectively, with the option to apply the standard retrospectively, for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Early adoption is permitted. We are currently evaluating the impact that the adoption of this guidance will have on our disclosures.
Recently Adopted Accounting Standards
There have been no new accounting pronouncements adopted in the period.



2. EARNINGS PER SHARE
We utilize the two-class method to report our earnings per share ("EPS"). The two-class method is an earnings allocation formula that determines earnings per share for each class of common stock according to dividends declared and participation rights in undistributed earnings. Common Stock is entitled to cash dividends equal to at least 133.33% on a per share basis of the cash dividend paid on Class B Stock. In computing earnings per share, the Company has allocated dividends declared to shares of Common Stock and Class B Stock based on amounts actually declared for each class of stock and 33.33% more of the undistributed earnings have been allocated to shares of Common Stock than to shares of Class B Stock on a per share basis. Common Stock is entitled to one vote per share and Class B Stock is entitled to ten votes per share. Common Stock have no conversion rights. Class B Stock is convertible by the holders thereof on a share-by-share basis into Common Stock at any time and is subject to mandatory conversion under certain circumstances. Basic EPS is computed by dividing net earnings, reduced for any distributed and undistributed earnings allocated to unvested restricted shares, by the weighted-average number of shares outstanding during the period for each class of common stock. Diluted EPS, for each class of common stock, is computed by dividing net earnings by the weighted-average number of common shares and potential common shares outstanding during the period. Dilution for Common Stock takes into consideration the effect of both unvested restricted shares and convertible shares of Class B Stock, if the effect is dilutive. Dilution for Class B Stock takes into consideration the effect of unvested restricted shares, if the effect is dilutive. Below is a reconciliation of the calculation of basic and diluted EPS.
13



For the Three Months Ended October 31, 2024
(in thousands, except for per share data)
TotalCommonClass B
Net income$16,376 $12,456 $3,920 
Distributed and undistributed earnings on restricted shares(817)(517)(300)
Income available to stockholders$15,559 $11,939 $3,620 
Net Income (Numerator)$11,939 $3,620 
Weighted Average Shares Outstanding (Denominator)4,922 1,984 
Basic EPS$2.43 $1.82 
Effect of dilution - Net Income (1)
$3,620 $ 
Net income assuming dilution (Numerator)$15,559 $3,620 
Effect of dilution - Shares (1)
1,984 $ 
Shares assuming dilution (Denominator)6,906 $1,984 
Diluted EPS$2.25 $1.82 
(1) The impact of 131,525 shares of unvested Common Stock and 62,663 shares of unvested Class B Stock was anti-dilutive therefore not included in the calculation of diluted EPS
For the Three Months Ended October 31, 2023
(in thousands, except for per share data)
TotalCommonClass B
Net income$10,742 $8,236 $2,506 
Distributed and undistributed earnings on restricted shares(570)(453)(117)
Income available to stockholders$10,172 $7,783 $2,389 
Net Income (Numerator)$7,783 $2,389 
Weighted Average Shares Outstanding (Denominator)4,827 1,967 
Basic EPS$1.61 $1.21 
Effect of dilution - Net Income (1)
$2,389 $ 
Net income assuming dilution (Numerator)$10,172 $2,389 
Effect of dilution - Shares (1)
1,967 $ 
Shares assuming dilution (Denominator)6,794 $1,967 
Diluted EPS$1.50 $1.21 
(1) The impact of 210,675 shares of unvested Common Stock and 54,370 shares of unvested Class B Stock was anti-dilutive therefore not included in the calculation of diluted EPS

14



3. INVENTORIES

The composition of inventories is as follows (in thousands):

October 31,
2024
July 31,
2024
Finished goods$34,130 $31,772 
Packaging8,563 8,995 
Spare parts
6,973 7,059 
Other6,359 6,410 
Total Inventories$56,025 $54,236 


Inventories are valued at the lower of cost (first-in, first-out) or net realizable value. Inventory costs include the cost of raw materials, packaging supplies, labor, and other overhead costs. The Company maintains reserves against inventory to reduce the carrying value to the expected net realizable value. These reserves are based upon a combination of factors including historical issues and market trends. Inventory reserves were $3.7 million and $3.8 million as of October 31, 2024 and July 31, 2024, respectively.


4. FAIR VALUE MEASUREMENTS

Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The inputs used to measure fair value are prioritized into categories based on the lowest level of input that is significant to the fair value measurement. The categories in the fair value hierarchy are as follows:

Level 1: Quoted market prices in active markets for identical assets or liabilities.
Level 2: Observable market-based inputs for similar assets or liabilities or valuation models whose inputs are observable, directly or indirectly.
Level 3: Unobservable inputs.

Cash equivalents are classified as Level 1 of the fair value hierarchy because they are valued using quoted market prices in active markets. These cash instruments are primarily money market funds and are included in cash and cash equivalents on the Consolidated Balance Sheets. We had $0.9 million in cash equivalents as of October 31, 2024 and $3.0 million in cash equivalents as of July 31, 2024.

Balances of accounts receivable, short-term investments and accounts payable approximated their fair values at October 31, 2024 and July 31, 2024 due to the short maturity and nature of those balances.

Debt is reported at outstanding face value, less unamortized debt issuance costs. The estimated fair value of debt, including current maturities, was $47.1 million and $51.1 million as of October 31, 2024 and July 31, 2024, respectively. The fair value was estimated using the exit price notion of fair value and is classified as Level 2. See Note 8 of the Notes to the Consolidated Financial Statements for further information about such debt.

We apply fair value techniques on at least an annual basis associated with: (1) valuing potential impairment loss related to goodwill, trademarks and other indefinite-lived intangible assets and (2) valuing potential impairment loss related to long-lived assets. See Note 5 of the Notes to the unaudited Condensed Consolidated Financial Statements for further information about goodwill and other intangible assets.


15



5. GOODWILL AND OTHER INTANGIBLE ASSETS

Our intangible assets are mainly comprised of customer lists, patents, trademarks, trade names and goodwill.
During fiscal year 2024, we recorded additions of intangible assets of $37.4 million related to the acquisition of Ultra Pet Company, Inc. ("Ultra Pet"), the components of which were $20.4 million of customer list, $5.2 million of trade name and $11.8 million of goodwill. During the first quarter of fiscal year 2025 we recognized a measurement period adjustment as a result of our acquisition of Ultra Pet, which increased our goodwill by $0.2 million.

We amortize customer lists and patents on a straight-line basis over periods ranging from 18 to 20 years. Estimated intangible amortization for fiscal year 2025 is $1.2 million. Estimated intangible amortization for each of the next five fiscal years is $1.2 million.

Trademarks and trade names acquired via acquisitions, with a carrying value of $5.6 million, were determined to have an indefinite life and are not amortized.


6. ACCRUED EXPENSES

Accrued expenses is as follows (in thousands):

October 31,
2024
July 31,
2024
Payables$9,522 $11,586 
Salaries, Wages, Commissions and Employee Benefits8,972 20,711 
Taxes4,352 1,736 
Freight4,033 2,928 
Trade promotions and advertising3,657 2,743 
Other2,087 3,104 
Georgia Landfill Modification Reserve
820 1,208 
$33,443 $44,016 


7. OTHER CONTINGENCIES

We are party to various legal actions from time to time that are ordinary in nature and incidental to the operation of our business, including ongoing litigation. While it is not possible at this time to determine with certainty the ultimate outcome of these or other lawsuits, we believe that none of the pending proceedings will have a material adverse effect on our business, financial condition, results of operations or cash flows.

In fiscal year 2023, we recorded a reserve for anticipated modification costs that we expected to incur to address capacity issues at our sole landfill located in Ochlocknee, Georgia. Reserves are recorded when it is probable that a liability has been incurred and the amount of the liability can be reasonably estimated. The amount of the reserve represented management’s best estimate of the costs for the modification with respect to this matter, at the time. Work began on the modifications during fiscal year 2024. During the first quarter of fiscal year 2025, we increased the total estimated cost by $0.4 million resulting in a total $3.5 million expense related to this matter. The modification work is expected to be completed during fiscal year 2025. Inherent uncertainties exist in these estimates primarily due to unknown conditions, changing governmental regulations and legal standards, and emerging technologies for handling site modification. Consequently, it is reasonably possible that modification costs in excess of amounts accrued could have a material impact on the Company’s results of operations, financial condition and cash flows.


8. DEBT

We are party to an Amended and Restated Note Purchase and Private Shelf Agreement (as amended, the "Note Agreement") with PGIM, Inc. ("Prudential") and certain existing noteholders and purchasers affiliated with Prudential named therein. Pursuant to the Note Agreement, (i) on May 15, 2020 we issued $10 million in aggregate principal amount of our 3.95% Series
16



B Senior Notes due May 15, 2030, of which $6 million aggregate principal amount remained outstanding as of October 31, 2024, (ii) on December 16, 2021, we issued an additional $25 million in aggregate principal amount of our 3.25% Series C Senior Notes due December 16, 2031, all of which remained outstanding as of October 31, 2024, and (iii) on April 30, 2024 we issued $10 million in aggregate principal amount of our 6.47% Series D Senior Notes due April 30, 2033, all of which remained outstanding as of October 31, 2024. The Note Agreement also provides us with the ability to request, from time to time, that Prudential affiliate(s) purchase, at Prudential’s discretion and on an uncommitted basis, additional senior unsecured notes of Oil-Dri (the “Shelf Notes,” and collectively with the Series A Senior Notes, Series B Senior Notes, Series C Senior Notes, and Series D Senior Notes, the “Notes”) in an aggregate principal amount of up to $75 million minus the aggregate principal amount of Notes then outstanding and Shelf Notes that have been accepted for purchase. Interest payable on any Shelf Note agreed to be purchased under the Note Agreement will be at a rate determined by Prudential and will mature no more than fifteen years after the date of original issue of such Shelf Note. On September 21, 2023, the Company entered into Amendment No. 4 to the Note Agreement extending the time frame for issuing and selling Shelf Notes to September 21, 2026.

We are party to the Credit Agreement, dated as of January 27, 2006 (as previously amended, the “Credit Agreement”), among us, BMO Harris Bank N.A (“BMO”), and certain of our domestic subsidiaries. The Credit Agreement provides for a $75 million unsecured revolving credit facility, including a maximum of $20 million for letters of credit.

The Credit Agreement contains restrictive covenants that, among other things and under various conditions, limit our ability to incur additional indebtedness or to dispose of assets. These restrictive covenants include certain financial covenants such as a covenant to maintain a maximum debt to earnings ratio and to maintain a certain fixed charge coverage ratio. On September 30, 2024, the Company entered into the Eighth Amendment to Credit Agreement (the “Eighth Amendment”). The Eighth Amendment amends the Credit Agreement to, among other things: increase the amount the Company may borrow from BMO from time to time pursuant to its revolving line of credit from up to $45 million to up to $75 million and to increase the aggregate maximum amount of letters of credit from up to $10 million to up to $20 million; add an accordion provision to allow the Company to increase the revolving line of credit by up to an additional $50 million, subject to the terms and conditions set forth in the Eighth Amendment; extend the termination date to September 30, 2029; and increase certain restrictive covenant thresholds, including but not limited to, an increase to the permitted acquisitions threshold in the restricted covenants from a cumulative total of $45 million to $100 million.

As of October 31, 2024, and July 31, 2024, we were in compliance with the covenants. There were no new borrowings during the first quarter of fiscal year 2025, however, on October 30, 2024 we elected to pay down $5 million of our total borrowings under the Credit Agreement. As of October 31, 2024 we had $5 million drawn at a 6.66% interest rate. We also had $2.9 million of letters of credit outstanding under the Credit Agreement as of both October 31, 2024 and July 31, 2024.
The Credit Agreement states that we may select a variable interest rate based on either the BMO prime rate or an adjusted SOFR-based rate, plus a margin that varies depending on our debt to earnings ratio, or a fixed rate as agreed between us and BMO. As of October 31, 2024, the variable rates would have been 8.00% for the BMO prime-based rate or 5.81% for the adjusted SOFR-based rate.


9. LEASES

We have operating leases primarily for real estate properties, including corporate headquarters, customer service and sales offices, manufacturing and packaging facilities, warehouses, and research and development facilities, as well as for rail tracks, railcars and office equipment. Certain of our leases for a shared warehouse and office facility, rail track and railcars have options to extend which we are reasonably certain we will exercise and, accordingly, have been considered in the lease term used to recognize our ROU assets and lease liabilities. To determine the present value of the lease liability, we use an incremental borrowing rate, which is defined as the rate of interest that the Company would have to pay to borrow (on a collateralized basis over a similar term) an amount equal to the lease payments in similar economic environments. Further information about our accounting policy for leases is included in Note 1 of the Notes to the unaudited Condensed Consolidated Financial Statements.

We have no material finance leases, and variable costs for operating leases are immaterial for the three months ended October 31, 2024. Operating lease costs are included in Cost of Goods Sold or SG&A expenses based on the nature of the lease. The following table summarizes total lease costs for our operating leases (in thousands):
17



For the Three Months Ended October 31,
20242023
Operating lease cost$1,370 $546 

Supplemental cash flow information related to leases was as follows (in thousands):
For the Three Months Ended October 31,
20242023
Cash paid for amounts included in the measurement of operating lease liabilities:$1,136 $461 
Right-of-use assets obtained in exchange for new operating lease liabilities$ $ 

Operating lease ROU assets and operating lease liabilities are separately presented on the unaudited Condensed Consolidated Balance Sheet, excluding leases with an initial term of twelve months or less. Other supplemental balance sheet information related to leases was as follows:
October 31, 2024July 31, 2024
Weighted-average remaining lease term - operating leases5.3 years5.4 years
Weighted-average discount rate - operating leases5.10%5.10%

Lease liability maturities as of October 31, 2024, are as follows (in thousands):
Fiscal year 2025 (remaining nine months)$4,061 
Fiscal year 20264,724 
Fiscal year 20273,758 
Fiscal year 20282,949 
Fiscal year 20292,356 
Thereafter3,480 
Total21,328 
Less: imputed interest(2,558)
Net lease obligation$18,770 


10. OPERATING SEGMENTS

We have two operating segments: (1) Retail and Wholesale Products Group and (2) Business to Business Products Group. These operating segments are managed separately and each segment's major customers have different characteristics. The Retail and Wholesale Products Group customers include mass merchandisers, the farm and fleet channel, drugstore chains, pet specialty retail outlets, dollar stores, retail grocery stores, distributors of industrial cleanup and automotive products, environmental service companies, sports field product users and marketers of consumer products. The Business to Business Products Group customers include: processors and refiners of edible oils, renewable diesel, petroleum-based oils and biodiesel fuel, manufacturers of animal feed and agricultural chemicals, and distributors of animal health and nutrition products. Our operating segments are also our reportable segments. The accounting policies of the segments are the same as those described in Note 1 of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended July 31, 2024.

18



Net sales for our principal products by segment are as follows (in thousands):

Business to Business Products GroupRetail and Wholesale Products Group
For the Three Months Ended October 31,
Product2024202320242023
Cat Litter$ $ $67,676 $60,861 
Industrial and Sports  11,854 $11,416 
Agricultural and Horticultural11,582 10,315   
Fluids Purification30,603 22,406  $ 
Animal Health & Nutrition6,230 6,440   
Net Sales$48,415 $39,161 $79,530 $72,277 

We do not rely on any segment asset allocations and we do not consider them meaningful because of the shared nature of our production facilities; however, we have estimated the segment asset allocations below for those assets for which we can reasonably determine. The unallocated asset category is the remainder of our total assets. The asset allocation is estimated and is not a measure used by our chief operating decision maker about allocating resources to the operating segments or in assessing their performance. 
 Assets
October 31, 2024July 31, 2024
 (in thousands)
Business to Business Products Group$100,325 $92,300 
Retail and Wholesale Products Group200,545 200,187 
Unallocated Assets49,301 62,118 
Total Assets$350,171 $354,605 

Net sales and operating income for each segment are provided below. The corporate expenses line includes certain unallocated expenses, including primarily salaries, wages and benefits, purchased services, rent, utilities and depreciation and amortization associated with corporate functions such as information systems, finance, legal, human resources and customer service. 

 For the Three Months Ended October 31,
 Net SalesIncome
 2024202320242023
  (in thousands)
Business to Business Products Group$48,415 $39,161 $17,110 $11,123 
Retail and Wholesale Products Group$79,530 72,277 $13,377 11,331 
Net Sales$127,945 $111,438 
Corporate Expenses(9,297)(9,298)
Income from Operations21,190 13,156 
Total Other Expenses, Net(988)(326)
Income before Income Taxes20,202 12,830 
Income Tax Expense(3,826)(2,088)
Net Income16,376 10,742 

19



11. STOCK-BASED COMPENSATION

The Amended and Restated Oil-Dri Corporation of America 2006 Long Term Incentive Plan, as amended (the "2006 Plan"), permits the grant of stock options, stock appreciation rights, restricted stock, restricted stock units, performance awards and other stock-based and cash-based awards. Our employees and outside directors are eligible to receive grants under the 2006 Plan. The total number of shares of stock subject to grants under the 2006 Plan may not exceed 1,719,500. As of October 31, 2024, there were 560,724 shares of Common Stock or Class B Stock available for future grants under this plan.

Restricted Stock

All of our non-vested restricted stock as of October 31, 2024 was issued under the 2006 Plan with vesting periods generally between one and five years. We determined the fair value of restricted stock as of the grant date. We recognize the related compensation expense over the period from the date of grant to the date the shares vest.

There were 40,800 and 57,000 restricted shares of Common Stock granted during the three months ended October 31, 2024 and 2023, respectively. There were no restricted shares of Class B Stock granted during the three months ended October 31, 2024 and 125,000 in the three months ended October 31, 2023. Stock-based compensation expense was $0.9 million and $0.8 million for the three months ended October 31, 2024 and 2023, respectively.

A summary of restricted stock transactions is shown below:
 Restricted Shares
(in thousands)
Weighted Average Grant Date Fair Value
(per share)
Non-vested restricted stock outstanding at July 31, 2024398 $49.63 
Granted41 $68.41 
Vested(78)$40.50 
Forfeitures(11)$53.66 
Non-vested restricted stock outstanding at October 31, 2024350 $53.75 


12. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS)

The following table summarizes the changes in accumulated other comprehensive income (loss) by component as of October 31, 2024 (in thousands):
 Postretirement Health BenefitsCumulative Translation AdjustmentTotal Accumulated Other Comprehensive Income (Loss)
Balance as of July 31, 2024$1,076 $(307)$769 
Other comprehensive income before reclassifications, net of tax (21)(21)
Amounts reclassified from accumulated other comprehensive income, net of tax(21) (21)
Net current-period other comprehensive (loss) income, net of tax(21)(21)(42)
Balance as of October 31, 2024$1,055 $(328)$727 


13. RELATED PARTY TRANSACTIONS
One member of our Board is currently the President and Chief Executive Officer of one of our vendors. Total payments to this vendor for fees and cost reimbursements were $0.3 million and $0.1 million for the first three months of fiscal years 2025 and 2024, respectively. There were $0.1 million of outstanding accounts payable due to that vendor as of both October 31, 2024 and July 31, 2024.
20




One member of our Board retired from the role of President and Chief Executive Officer of one of our customers on September 28, 2019 and is currently party to a post-employment consulting agreement with this customer. Total sales to that customer, including sales to its subsidiaries, were $0.1 million for the first three months of both fiscal years 2025 and 2024. There were no outstanding amounts due from that customer as of either October 31, 2024 or July 31, 2024.


21



ITEM 2.  MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The following discussion and analysis of our financial condition and results of operations should be read together with the financial statements and the related notes included herein and our Consolidated Financial Statements, accompanying notes and Management’s Discussion and Analysis of Financial Condition and Results of Operations contained in our Annual Report on Form 10-K for the fiscal year ended July 31, 2024. This discussion contains forward-looking statements that involve risks and uncertainties. Our actual results may differ materially from the results discussed in the forward-looking statements. Factors that might cause a difference include, but are not limited to, those discussed herein under "Forward-Looking Statements" and "Risk Factors," and those discussed under Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended July 31, 2024.

OVERVIEW

We develop, mine, manufacture and market sorbent products principally produced from clay minerals, primarily consisting of calcium bentonite, attapulgite and diatomaceous shale. Our principal products include agricultural and horticultural chemical carriers, animal health and nutrition products, cat litter, fluids purification and filtration bleaching clays, industrial and automotive floor absorbents and sports field products. Our products are sold to two primary customer groups, including customers who resell our products as originally produced to the end consumer and other customers who use our products as part of their production process or use them as an ingredient in their final finished product. We have two reportable operating segments based on the different characteristics of our two primary customer groups: the Retail and Wholesale Products Group ("Retail and Wholesale" or "R&W") and the Business to Business Products Group ("Business to Business" or "B2B"), as described in Note 10 of the Notes to the unaudited Condensed Consolidated Financial Statements. Each operating segment is discussed individually below.

RESULTS OF OPERATIONS

OVERVIEW

Quarterly net sales, gross profit and net income reached all-time highs in the three months ended October 31, 2024. Net sales grew across both the Retail and Wholesale Products Group and the Business to Business Products Group. Both operating segments grew due to higher volumes and favorable mix compared to the same period in fiscal year 2024. Consolidated net sales of $127.9 million increased $16.5 million, or 15%, in the three months ended October 31, 2024 compared to the three months ended October 31, 2023. Gross margin grew to 32% for the three months ended October 31, 2024 compared to 28% for the three months ended October 31, 2023.

Despite higher SG&A and other expenses including tax, consolidated income from operations increased $8.0 million, or 61%, and net income increased $5.6 million, or 52%, for the three months ended October 31, 2024 compared to the three months ended October 31, 2023.

Our Condensed Consolidated Balance Sheet as of October 31, 2024 and our Condensed Consolidated Statement of Cash Flows for the three months ended October 31, 2024 show an decrease in total cash and cash equivalents from fiscal year-end 2024. The decrease was driven primarily due to the use of cash in investing and financing activities which included capital expenditures, partial payment on our revolving credit facility, dividend payments and treasury stock repurchases. These were partially offset by positive cash flow from operations. Refer to the "Liquidity and Capital Resources" section below for more details.

THREE MONTHS ENDED OCTOBER 31, 2024 COMPARED TO
THREE MONTHS ENDED OCTOBER 31, 2023

CONSOLIDATED RESULTS

Consolidated net sales for the three months ended October 31, 2024 were $127.9 million, a 15% increase compared to net sales of $111.4 million for the three months ended October 31, 2023. The increase was primarily driven by higher volumes and favorable mix in both our Business to Business and Retail and Wholesale product groups.

Consolidated gross profit in the three months ended October 31, 2024 was $40.8 million, an increase of $9.8 million, or 32%, from gross profit of $31.0 million in the three months ended October 31, 2023. Our gross margin (defined as gross profit as a percentage of net sales) in the three months ended October 31, 2024 increased to 32% from 28% in the three months ended
22



October 31, 2023. This gross margin expansion was mainly driven by volume growth, which led to improved fixed cost coverage, and favorable product mix. Additionally, we realized production efficiencies at various manufacturing plants which resulted in stronger gross margins for several of our products. While some per ton costs such as transportation have increased, overall cost pressures have lessened and have been mitigated by the positive impact of volume and mix. This resulted in overall per ton cost of goods sold, for the three months ended October 31, 2024, to remain flat when compared to the same period last year.

Total SG&A expenses of $19.6 million for the three months ended October 31, 2024 were higher by $1.8 million, or 10%, compared to $17.8 million for the three months ended October 31, 2023. Corporate unallocated expenses remained flat year over year as the increase was driven by segments' SG&A. The discussion of the segments' operating incomes below describes the changes in SG&A expenses that were allocated to the operating segments.

Total other expenses, net were $1.0 million for the three months ended October 31, 2024 compared to $0.3 million in the same period of fiscal year 2024. The increase was mainly due to higher interest expenses an increase in the estimated landfill modification cost. Refer to Note 7 of the Notes to the unaudited Condensed Consolidated Financial Statements for additional details regarding the landfill modification accrual.

Consolidated net income before taxes for the three months ended October 31, 2024 was $20.2 million compared to $12.8 million for the three months ended October 31, 2023. Results for the three months ended October 31, 2024 were driven by the factors discussed above.

We had tax expense of $3.8 million for the three months ended October 31, 2024 compared to $2.1 million for the three months ended October 31, 2023. Our tax expense was driven primarily by higher net income. We used an estimated annual effective tax rate ("ETR") of 19% in determining our provision for income taxes, which is based on expected annual taxable income and the assessment of various tax adjustments, including depletion and discrete items.

Consolidated quarterly net income reached a record $16.4 million in the three months ended October 31, 2024, an increase of $5.6 million or 52%, from $10.7 million for the three months ended October 31, 2023.

BUSINESS TO BUSINESS PRODUCTS GROUP

Net sales of the Business to Business Products Group for the three months ended October 31, 2024 were $48.4 million, an increase of $9.3 million, or 24%, from net sales of $39.2 million for the three months ended October 31, 2023, driven by sales of our fluids purification and agricultural products. Net sales of our fluids purification products increased $8.2 million, or 37%, in the three months ended October 31, 2024 compared to the three months ended October 31, 2023. The increase was primarily driven by new and growing demand in the renewable diesel business and, to a lesser extent, higher prices. Net sales increased in all regions except for our subsidiary in the U.K. which is further discussed below. Net sales of our agricultural and horticultural chemical carrier products increased $1.3 million, or 12%, for the three months ended October 31, 2024 compared to the three months ended October 31, 2023 as a result of stronger demand and, to a lesser extent, higher prices. The volume growth was primarily due to key customers who resumed purchasing after working through inventory surpluses. Net sales of our animal health & nutrition products decreased $0.2 million, or 3%, during the three months ended October 31, 2024 compared to three months ended October 31, 2023. The decrease was driven by the Asia region (including China) and our subsidiary in Mexico, partially offset by higher sales in North America and Latin America. Net sales in Asia were down due to the sell off of existing inventory that occurred in the first quarter of fiscal year 2024 as we transitioned to a master distributor in China. Net sales in Latin America grew due to higher demand of exiting and new customers specifically in Brazil while net sales in North America grew due to higher prices and, to a lesser extent, growth in demand.

SG&A expenses for the Business to Business Products Group increased by $0.7 million, or 20%, for the three months ended October 31, 2024 compared to the three months ended October 31, 2023. The increase was mainly driven by a preliminary foreign value-added tax ("VAT") assessment and higher research and development costs.

The Business to Business Products Group’s operating income for the three months ended October 31, 2024 was $17.1 million, an increase of $6.0 million, or 54%, from operating income of $11.1 million for the three months ended October 31, 2023. The increase in operating income was mostly driven by higher sales in our fluids purification and agricultural products.

23



RETAIL AND WHOLESALE PRODUCTS GROUP

Net sales of the Retail and Wholesale Products Group for the three months ended October 31, 2024 were $79.5 million, an increase of $7.3 million, or 10%, from net sales of $72.3 million for the three months ended October 31, 2023. This increase was mainly driven by sales of our new crystal cat litter products and stronger demand for our co-packaged cat litter and industrial products. Total global cat litter net sales for the three months ended October 31, 2024 increased $6.8 million, or 11%, compared to the three months ended October 31, 2023, driven primarily by sales of our new crystal cat litter products and higher demand in our co-packaged business partially offset by a decrease in our clay based cat litter sales. Net sales of co-packaged cat litter increased $2.1 million, or 78%, compared to the three months ended October 31, 2024 due to higher demand. In the first quarter of fiscal year 2024, a cyber-attack disrupted a key customer’s ability to place and receive orders, which negatively impacted sales of Oil-Dri’s co-packaged coarse litter. However, the cyber event boosted sales of the Oil-Dri’s branded and private label coarse items, and is currently influencing year-over-year comparisons for both domestic clay and co-packaged litter products. Although total domestic clay litter revenues declined, Oil-Dri continued to experience topline growth of its EPA-approved Cat’s Pride Antibacterial Clumping Litter which is currently sold at large brick and mortar and e-commerce retailers. In addition, new distribution of other clay products and accessories was achieved at new and existing customers. Net sales of cat litter by our subsidiary in Canada decreased slightly period over period, as discussed in "Foreign Operations" below. Net sales of our global industrial and sports products increased $0.4 million, or 4%, compared to the three months ended October 31, 2023, primarily driven by increased demand of our clay-based floor absorbent products by new and existing customers.

SG&A expenses for the Retail and Wholesale Products Group were $1.0 million, or 21%, higher during the three months ended October 31, 2024 compared to the three months ended October 31, 2023, primarily due to higher compensation related costs, a credit reserve for several customer bankruptcies, amortization of the customer list acquired with Ultra Pet and higher research and development costs. These higher expenses were partially offset by lower advertising expense in the first quarter of fiscal year 2025 compared to the first quarter of fiscal year 2024. We anticipate total advertising expense in fiscal year 2025 to be lower than fiscal year 2024.

The Retail and Wholesale Products Group's operating income for the three months ended October 31, 2024 was $13.4 million, an increase of $2.1 million, or 18%, from operating income of $11.3 million for three months ended October 31, 2023. This was driven primarily by higher volumes including new crystal cat litter sales, partially offset by elevated SG&A expenses, as discussed above.

FOREIGN OPERATIONS

Foreign operations include our subsidiaries in Canada and Netherlands, which are reported in the Retail and Wholesale Products Group, and our subsidiaries in the United Kingdom ("UK"), Mexico, China and Indonesia, which are reported in the Business to Business Products Group. Net sales by our foreign subsidiaries for the three months ended October 31, 2024 were $5.1 million, a decrease of 27%, compared to net sales of $7.0 million during the three months ended October 31, 2023. The decrease was driven mainly by our subsidiary in China and, to a lesser extent, all other subsidiaries. Net sales of our subsidiary in China decreased $1.7 million, or 100%, in the three months ended October 31, 2024 compared to the same period of fiscal year 2024 due to a sell-off of all existing inventory to a new master distributor, which occurred in the first quarter of fiscal year 2024. Sales to China are now directly through the Company and not through our subsidiary in China. Total net sales of our subsidiary in Canada decreased $0.1 million, or 2%, in the three months ended October 31, 2024 compared to the three months ended October 31, 2023, driven by softer sales volumes of cat litter partially offset by higher net sales of floor absorbents due to higher prices. Net sales of our subsidiaries in the UK and Mexico decreased slightly in the three months ended October 31, 2024 compared to the three months ended October 31, 2023. Net sales by our foreign subsidiaries represented 4% and 6% of our consolidated net sales for the three months ended October 31, 2024 and 2023, respectively.

Our foreign subsidiaries reported net loss of $0.2 million for the three months ended October 31, 2024, compared to net income of $0.6 million in the three months ended October 31, 2023. The decrease in net income was primarily driven by the decrease in China sales as well as the preliminary foreign VAT assessment recognized in the quarter.

Identifiable assets of our foreign subsidiaries as of October 31, 2024, were $9.2 million, compared to $8.7 million as of July 31, 2024.

LIQUIDITY AND CAPITAL RESOURCES

Our principal liquidity needs are to fund our capital requirements, including funding working capital needs; purchasing and upgrading equipment, facilities, information systems, and real estate; supporting new product development; investing in
24



infrastructure; repurchasing stock; paying dividends; and, from time to time, business acquisitions, and funding our debt service requirements. During the three months ended October 31, 2024, we principally funded these short and long-term capital requirements using cash from current operations as well as cash generated from previous borrowings under our Series B, C and D Senior Notes and Credit Agreement. On September 30, 2024 we amended the Credit Agreement to, among other things, increase our line of credit from $45 million to $75 million in order to gain extra flexibility in our cash position. See Note 8 of the Notes to the unaudited Condensed Consolidated Financial Statements in this Quarterly Report on Form 10-Q for further information relating to our existing borrowings.

We currently anticipate cash flows from operations and our available sources of liquidity will be sufficient to meet our cash requirements. In addition, we are actively monitoring the timing and collection of our accounts receivable.
The following table sets forth certain elements of our unaudited Condensed Consolidated Statements of Cash Flows (in thousands):
 For the Three Months Ended October 31,
 20242023
Net cash provided by operating activities$10,919 $8,564 
Net cash used in investing activities(12,817)(8,064)
Net cash used in financing activities
(9,080)(2,799)
Effect of exchange rate changes on cash and cash equivalents3 124 
Net increase in cash and cash equivalents$(10,975)$(2,175)

Net cash provided by operating activities

In addition to net income, as adjusted for depreciation and amortization and other non-cash operating activities, the primary sources and uses of operating cash flows for the three months ended October 31, 2024 were as follows:

Accounts receivable, net of allowances increased by $9.0 million in the three months ended October 31, 2024. The increase in accounts receivable was driven primarily by higher net sales, offset by the level and timing of collections due to payment terms.

Inventory increased by $2.0 million in the three months ended October 31, 2024 due to the building of finished goods inventory to meet anticipated demand.

Prepaid expenses decreased by $2.2 million in the three months ended October 31, 2024. The decrease is mainly due to the timing of tax and insurance payments.

Excluding the impact of payments related to capital expenditures, accounts payable increased by $1.9 million in the three months ended October 31, 2024. The increase was mainly due to the timing of payments, cost of goods and services we purchase, production volume levels and vendor payment terms. In the three months ended October 31, 2024 there was a $3.0 million decrease in accounts payable related to capital expenditures recognized as cash used in investing activities

Excluding the impact of payments made related to capital expenditures, accrued expenses decreased $6.1 million in the three months ended October 31, 2024. The decrease was mainly due to the payout of annual bonuses and taxes, and other miscellaneous expenses which fluctuate due to timing of payments, changes in the cost of goods and services we purchase, production volume levels and vendor payment terms including freight. In the three months ended October 31, 2024 there was a $4.5 million decrease in accrued expenses related to capital expenditures recognized as cash used in investing activities

Net cash used in investing activities

Cash used in investing activities of $12.8 million in the three months ended October 31, 2024 was driven by capital expenditures. During the three months ended October 31, 2024 we continued to expand our plant equipment and improve our facilities to support increased demand for our products.

25



Net cash used in financing activities

Cash used in financing activities of $9.1 million in the three months ended October 31, 2024 was primarily driven by a $5 million payment of our borrowing under the Credit Agreement, as well as cash used for dividend payments and treasury stock repurchases.

Other

Total cash balances held by our foreign subsidiaries of $4.7 million as of October 31, 2024 decreased compared to $4.5 million as of July 31, 2024. See further discussion in "Foreign Operations" above.

As of October 31, 2024, we had remaining authority to repurchase 368,902 shares of Common Stock and 244,113 shares of Class B Stock under a repurchase plan approved by our Board. Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by our management pursuant to the repurchase plan approved by our Board.

We believe that cash flow from operations, availability under our Note Agreement and revolving credit facility under our Credit Agreement, current cash balances and our ability to obtain other financing, if necessary, will provide sufficient liquidity for foreseeable working capital needs, capital expenditures at existing facilities, deferred compensation payouts, dividend payments and debt service obligations for at least the next 12 months.

We continually evaluate our liquidity position and anticipated cash needs, as well as the financing options available to obtain additional cash reserves. Our ability to fund operations, to make planned capital expenditures, to make scheduled debt payments and to remain in compliance with all financial covenants under debt agreements, including, but not limited to, the Credit Agreement, depends on our future operating performance, which, in turn, is subject to prevailing economic conditions and to financial, business and other factors. The timing and size of any new business ventures or acquisitions that we complete may also impact our cash requirements.

CRITICAL ACCOUNTING POLICIES AND ESTIMATES

This discussion and analysis of financial condition and results of operations is based on our unaudited Condensed Consolidated Financial Statements, which have been prepared in accordance with U.S. GAAP for interim financial information and in compliance with instructions to Form 10-Q and Article 10 of Regulation S-X. The preparation of these financial statements requires the use of estimates and assumptions related to the reporting of assets, liabilities, revenues, expenses and related disclosures. In preparing these financial statements, we have made our best estimates and judgments of certain amounts included in the financial statements. Estimates and assumptions are revised periodically. Actual results could differ from these estimates. See the information concerning our critical accounting policies included under "Management’s Discussion of Financial Condition and Results of Operations" in our Annual Report on Form 10-K for the fiscal year ended July 31, 2024.

ITEM 3.  QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

We are exposed to market risks in the ordinary course of our business. These risks primarily include changes in commodity prices, interest rates, foreign currency exchange rates, and duties and tariffs, along with the impact of inflation. We do not engage in financial transactions for trading or speculative purposes.

Commodity Prices Risk. We are primarily exposed to fluctuations in market prices with respect to the commodities necessary for producing, packaging, and shipping our products, and in particular with respect to fuel. Factors that could influence the cost of natural gas used in the kilns to dry our clay include the creditworthiness of our natural gas suppliers, the overall general economy, developments in world events, general supply and demand for natural gas, seasonality and the weather patterns throughout the United States and the world. We monitor fuel market trends and, consistent with our past practice, we may contract for a portion of our anticipated fuel needs using forward purchase contracts to mitigate the volatility of our kiln fuel prices. During fiscal years 2024 and 2023, we purchased several forward fuel contracts in Georgia and California which will cover a portion of our needs through fiscal year 2026. These contracts totaled approximately $4.3 million in fiscal year 2024, and a 10% change in the market price for fuel would have resulted in an additional pretax gain or loss of approximately $0.4 million as the related inventory containing those inputs was sold.

Interest Rate Risk. The interest payable on amounts borrowed pursuant to our Credit Agreement is based on variable interest rates and is therefore affected by changes in interest rates. In addition, we have investments consisting of cash, cash equivalents and short-term investments which are also affected by changes in interest rates. Based on our current and expected levels of
26



borrowing and investing, we do not expect changes in interest rates to have a material impact on our results of operations or financial position.

Foreign Currency Risk. We are exposed to foreign currency risk, primarily the U.S. dollar relative to the local currency in the foreign markets we do business in. This risk is related to our foreign subsidiaries' financial results, to certain accounts receivable and to our ability to sell in foreign markets. We are subject to the impact of currency fluctuation upon translation of our foreign subsidiaries’ financial statements from local currencies to U.S. dollars. In recent years, our foreign subsidiaries have not generated a substantial portion of our consolidated net sales or net income. In addition, the portion of our consolidated accounts receivable denominated in foreign currencies has not been significant. Finally, foreign net sales of our products may be influenced by the relative strength of the U.S. dollar compared to various other currencies, which makes our products relatively more or less expensive than our foreign competitors' products in local marketplaces. We do not enter into any hedge contracts to offset any adverse effect of changes in currency exchange rates. Foreign currency fluctuations did not have a material impact on our results of operations or financial position during any of the fiscal periods presented, and we do not expect changes in foreign currency rates to have a material impact on our results of operations or financial position.

Duties and Tariffs Market Risk. We are exposed to market risk with respect to duties and tariffs assessed on raw materials, component parts, and finished goods we import. Additionally, we are exposed to duties and tariffs on our finished goods that we export from our manufacturing plants. As these tariffs and duties increase, we determine whether a price increase to our customers to offset these costs is warranted. To the extent that an increase in these costs would have a material impact on our results of operations, we believe that our competitors would experience a similar impact.

Inflation Risk. Our results of operations and financial condition are presented based on historical cost. While it is difficult to accurately measure the impact of inflationary pressure, we believe any inflationary impact on our product and operating costs would be offset by our ability to increase selling prices, create operational efficiencies and seek lower cost alternatives.

ITEM 4.  CONTROLS AND PROCEDURES

Evaluation of Disclosure Controls and Procedures

Management conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the "Exchange Act")) as of the end of the period covered by this Quarterly Report on Form 10-Q. The controls evaluation was conducted under the supervision and with the participation of management, including our Chief Executive Officer ("CEO") and Chief Financial Officer ("CFO"). Based upon the controls evaluation, our CEO and CFO have concluded that, as of the end of the period covered by this report, our disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in our Exchange Act reports is recorded, processed, summarized and reported within the time periods specified by the SEC, and that such information is accumulated and communicated to management, including the CEO and CFO, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) that occurred during the fiscal quarter ended October 31, 2024 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

27



Inherent Limitations on Effectiveness of Controls

Our management, including the CEO and CFO, do not expect that our disclosure controls and procedures or our internal control over financial reporting will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the control system’s objectives will be met. The design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Further, because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, within the Company have been detected. These inherent limitations include the realities that judgments in decision-making can be faulty and that breakdowns can occur because of simple error or mistake. Controls can also be circumvented by the individual acts of some persons, by collusion of two or more people, or by management override of the controls. The design of any system of controls is based in part on certain assumptions about the likelihood of future events, and there can be no assurance that any design will succeed in achieving its stated goals under all potential future conditions. Projections of any evaluation of controls effectiveness to future periods are subject to risks. Over time, controls may become inadequate because of changes in conditions or deterioration in the degree of compliance with policies or procedures.

PART II – OTHER INFORMATION

Items 1, 3, and 5 of this Part II are either inapplicable or are answered in the negative and are omitted pursuant to the instructions to Part II of Form 10-Q.

ITEM 1A. RISK FACTORS

Our operations and financial results are subject to various risks and uncertainties, including those described in Part I, Item 1A, "Risk Factors," of our Annual Report on Form 10-K for the fiscal year ended July 31, 2024. There have been no material changes to our risk factors since our Annual Report on Form 10-K for the fiscal year ended July 31, 2024.

28


ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

During the three months ended October 31, 2024, we did not sell any securities which were not registered under the Securities Act of 1933, as amended. The following table summarizes our Common Stock purchases by or on behalf of the Company or any affiliated purchaser (as defined in Rule 10b-18(a)(3) under the Exchange Act) during this period.
ISSUER PURCHASES OF EQUITY SECURITIES1, 2
(a)(b)(c)(d)
Period
Total Number of Shares Purchased3
Average Price Paid per ShareTotal Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Maximum Number of Shares that may yet be Purchased Under Plans or Programs4
August 1, 2024 to August 31, 2024$—379,925
September 1, 2024 to September 30, 2024$—379,925
October 1, 2024 to October 31, 202411,023$68.45368,902
Class B Stock
August 1, 2024 to August 31, 2024$—262,092
September 1, 2024 to September 30, 2024$—262,092
October 1, 2024 to October 31, 202417,979$68.43244,113

1 The table summarizes repurchases of (and remaining authority to repurchase) shares of our Common Stock and Class B Stock. No shares of our Class A Common Stock are currently outstanding. Descriptions of our Common Stock, Class B Stock and Class A Common Stock are contained in Exhibit 4.1 of our Annual Report on Form 10-K for the fiscal year ended July 31, 2024.

2 The figures in the table reflect transactions according to the settlement dates. For purposes of our unaudited Condensed Consolidated Financial Statements included in this Quarterly Report on Form 10-Q, the impact of repurchases are recorded according to the settlement dates.

3 All purchased shares were surrendered by employees to pay taxes related to restricted stock awards.

4 Our Board authorized the repurchase of 750,000 shares of Common Stock on March 11, 2019. This authorization does not have a stated expiration date. The share numbers in this column indicate the number of shares of Common Stock that may yet be repurchased under this authorization. Repurchases may be made on the open market (pursuant to Rule 10b5-1 plans or otherwise) or in negotiated transactions. The timing, number and manner of share repurchases will be determined by management.


ITEM 4.  MINE SAFETY DISCLOSURES

Our mining operations are subject to regulation by the Mine Safety and Health Administration under authority of the Federal Mine Safety and Health Act of 1977, as amended. Information concerning mine safety violations or other regulatory matters required by section 1503(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S-K are included in Exhibit 95 to this Quarterly Report on Form 10-Q.


29


ITEM 6.  EXHIBITS
Exhibit
No.
DescriptionSEC Document Reference
10.1Incorporated by reference to Exhibit 10.1 to Oil-Dri Corporation of America’s Current Report on Form 8-K filed on September 30, 2024
31Filed herewith.
32Furnished herewith.
95Filed herewith.
101.SCHXBRL Taxonomy Extension Schema DocumentFiled herewith.
101.CALXBRL Taxonomy Extension Calculation Linkbase DocumentFiled herewith.
101.DEFXBRL Taxonomy Extension Definition Linkbase DocumentFiled herewith.
101.LABXBRL Taxonomy Extension Labels Linkbase DocumentFiled herewith.
101.PREXBRL Taxonomy Extension Presentation LinkbaseFiled herewith.
104
Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)
Filed herewith.

Note: Stockholders may receive copies of the above listed exhibits, without fee, by written request to Investor Relations, Oil-Dri Corporation of America, 410 North Michigan Avenue, Suite 400, Chicago, Illinois 60611-4213, by telephone at (312) 321-1515 or by e-mail to info@oildri.com.

30


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


OIL-DRI CORPORATION OF AMERICA
(Registrant)


BY /s/ Daniel S. Jaffee                          
Daniel S. Jaffee
Chairman, President and Chief Executive Officer


BY /s/ Susan M. Kreh                         
Susan M. Kreh
Chief Financial Officer


Dated:  December 9, 2024
31